Status:
COMPLETED
Pharmacotherapy and Intensive Treatment - 2
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborating Sponsors:
VA Office of Research and Development
Conditions:
Cocaine-Related Disorders
Substance-Related Disorders
Eligibility:
FEMALE
18-60 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
Eligibility Criteria
Please contact site for information.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
June 1 2005
Estimated Enrollment :
353 Patients enrolled
Trial Details
Trial ID
NCT00000218
End Date
June 1 2005
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas
Kansas City, Missouri, United States, 64128